F m Investments LLC Boosts Stock Position in HCA Healthcare, Inc. $HCA

F m Investments LLC boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 94.8% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 20,758 shares of the company’s stock after acquiring an additional 10,101 shares during the quarter. F m Investments LLC’s holdings in HCA Healthcare were worth $8,847,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of HCA. Clearstead Trust LLC increased its stake in shares of HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. boosted its holdings in HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after buying an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the second quarter valued at approximately $40,000. Compound Global Advisors LLC acquired a new stake in shares of HCA Healthcare in the third quarter worth approximately $44,000. Finally, True Wealth Design LLC raised its stake in HCA Healthcare by 179.5% in the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after purchasing an additional 70 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $533.39 on Friday. The company has a 50-day moving average of $507.05 and a two-hundred day moving average of $469.55. The firm has a market cap of $119.28 billion, a PE ratio of 18.79, a price-to-earnings-growth ratio of 1.63 and a beta of 1.34. HCA Healthcare, Inc. has a 1-year low of $313.21 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the prior year, the business posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.99%.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at $6,171,357.94. This represents a 40.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This represents a 16.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 15,214 shares of company stock valued at $7,797,595. Insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on HCA shares. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 29th. KeyCorp set a $503.00 price objective on shares of HCA Healthcare in a report on Wednesday, January 28th. Argus boosted their target price on HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Truist Financial lifted their price objective on HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, Robert W. Baird raised their target price on HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Sixteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $537.73.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.